Dirk Sauer
Directeur/Bestuurslid bij Iconic Therapeutics, Inc.
Vermogen: 8 066 $ op 31-05-2024
Oorsprong van het eerstegraads netwerk van Dirk Sauer
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Novartis International AG
 Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland.
22
| Subsidiary | Pharmaceuticals: Major | 22 |
Iconic Therapeutics, Inc.
 Iconic Therapeutics, Inc. BiotechnologyHealth Technology Iconic Therapeutics, Inc. engages in the development of novel therapeutics for the treatment of serious eye disorders. Its product ICON-1, is a novel immune-conjugate fusion protein that works with the body’s immune system to address the root causes of inflammation and angiogenesis together, potentially altering the course of causes of blindness. The company was founded by Alan Garen, Kirk Dornbush, and Michael I. Sherman in 2003 and is headquartered in South San Francisco, CA.
7
| Subsidiary | Biotechnology | 7 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Dirk Sauer via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| NOVARTIS AG | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Compliance Officer Chief Executive Officer | |
| Harvard Business School | College/University | Graduate Degree Masters Business Admin Masters Business Admin | |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Chairman Chief Executive Officer Director of Finance/CFO | |
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal General Counsel | |
| The University of Chicago | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Doctorate Degree Corporate Officer/Principal | |
Novartis Vaccines & Diagnostics, Inc.
 Novartis Vaccines & Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Novartis Vaccines & Diagnostics, Inc. manufactures and markets health care and nutritional products. The company was founded in 1986 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | President President | |
Novartis Pharma Schweiz AG
 Novartis Pharma Schweiz AG Miscellaneous Commercial ServicesCommercial Services Novartis Pharma Schweiz AG engages in the marketing and distribution of pharmaceutical, chemical, and medical products of the Novartis group. Its products are used in the treatment of diseases in the areas of neurology, immunology, dermatology, ophthalmology, cardiology, and oncology. The company was founded on December 10, 1986 and is headquartered in Rotkreuz, Switzerland. | Miscellaneous Commercial Services | Corporate Officer/Principal Director of Finance/CFO | |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor | |
Novartis Pharmaceuticals
 Novartis Pharmaceuticals Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis Pharmaceuticals is a German company that manufactures pharmaceutical products. The company is based in Basel, Germany. | Pharmaceuticals: Major | President Corporate Officer/Principal | |
Novartis Korea Co., Ltd.
 Novartis Korea Co., Ltd. Drugstore ChainsRetail Trade Novartis Korea Ltd. engages in the manufacture and sale of pharmaceutical products. The company was founded on September 20, 1984 and is headquartered in Seoul, South Korea. | Drugstore Chains | President Chief Executive Officer | |
Semma Therapeutics, Inc.
 Semma Therapeutics, Inc. BiotechnologyHealth Technology Semma Therapeutics, Inc. develops transformative therapies for patients who currently depend on insulin injections. It focuses on combining proprietary cells with a state-of-the-art device to provide a true replacement for the missing beta cells in a diabetic patient without immunosuppression. The company was founded by Robert A. Millman, Walter A. Blättler, Felicia Pagliuca, Jeff Imbaro and Douglas A. Melton in 2015 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Chief Executive Officer | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| University of Pennsylvania | College/University | Undergraduate Degree Undergraduate Degree | |
| Novartis Pharma BV | Corporate Officer/Principal Chief Executive Officer | ||
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Miscellaneous Commercial Services | Director/Board Member | |
| CULLINAN THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Entasis Therapeutics, Inc.
 Entasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Entasis Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovey, development, and commercialization of novel antibacterial prodcuts to treat serious infections caused by multi-drug resistant Gram-negative bacteria. Its pipeline includes ETX2514SUL, targeting Acinetobacter baumannii infections; ETX0282CPDP, targeting Enterobacteriaceae infections; a Non-Beta-lactam PBP inhibitor, targeting Gram-negative infections; and zoliflodacin, targeting Neisseria gonorrhoeae. The company was founded by Manoussos Perros in May 2015 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Chairman | |
FerGene, Inc.
 FerGene, Inc. BiotechnologyHealth Technology FerGene, Inc. provides gene therapy solutions to urologists. The company is headquartered in Cambridge, MA. | Biotechnology | Chief Executive Officer | |
| Camping & Education Foundation | Director/Board Member | ||
Stargazer Pharmaceuticals, Inc.
 Stargazer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Stargazer Pharmaceuticals, Inc. manufactures pharmaceutical products. The firm engages in the development of treatment for Stargardt’s disease, a rare form of juvenile, retinal degeneration. The company was founded by Gary Jay Sternberg and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member | |
| MIRATI THERAPEUTICS | Biotechnology | Chief Executive Officer | |
| ENTASIS THERAPEUTICS HOLDINGS INC. | Biotechnology | Chairman | |
| UNIQURE N.V. | Biotechnology | Chairman | |
Novartis Pharmaceuticals Canada, Inc.
 Novartis Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Canada, Inc. manufactures chemicals and pharmaceuticals products. It provides solutions on patients suffering from a variety of major illnesses including cancer, cardiovascular diseases, Alzheimer's disease, age-related macular degeneration, organ transplantation, and osteoporosis. The company was founded in 1996 and is headquartered in Dorval, Canada. | Pharmaceuticals: Major | Chief Executive Officer | |
Ipsen Pharma SAS
 Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Ipsen Pharma SAS is a biopharmaceutical company that develops medicines in oncology, neuroscience and rare diseases. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France. | Pharmaceuticals: Major | Chairman | |
Ipsen Manufacturing Ireland Ltd.
 Ipsen Manufacturing Ireland Ltd. BiotechnologyHealth Technology Ipsen Manufacturing Ireland Ltd. operates as a biopharmaceutical group dedicated to improving lives through innovative medicines. The company was founded in 1989 and is headquartered in Dublin, Ireland. | Biotechnology | Chief Executive Officer | |
| FUSN PHAR | Pharmaceuticals: Major | Director/Board Member | |
McKinsey GmbH & Co. KG
 McKinsey GmbH & Co. KG Miscellaneous Commercial ServicesCommercial Services McKinsey GmbH & Co. KG provides business consulting services. The company was founded on October 18, 2011 and is headquartered in Düsseldorf, Germany. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| CAREDX, INC | Medical Specialties | Director/Board Member | |
| Blulake Ventures LLC | Director/Board Member | ||
Novartis Pharma SAS
 Novartis Pharma SAS Pharmaceuticals: MajorHealth Technology Novartis Pharma SAS wholesales and distributes pharmaceutical products. It offers generic and branded drugs and medicines. The company is headquartered in Rueil-Malmaison, France. | Pharmaceuticals: Major | Chairman | |
Helsinn Healthcare SA
 Helsinn Healthcare SA Pharmaceuticals: MajorHealth Technology Helsinn Healthcare SA develops and provides licenses for drugs. The firm offers services to oncology, cancer supportive care, pain and inflammation, gastrointestinal fields. The company was founded by Gabriele Braglia in 1976 and is headquartered in Pazzallo, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
| STADA ARZNEIMITTEL | Pharmaceuticals: Major | Director/Board Member | |
| University of California, Berkeley | College/University | Graduate Degree | |
| University of Basel | College/University | Doctorate Degree | |
Zuellig Pharma Corp.
 Zuellig Pharma Corp. Pharmaceuticals: MajorHealth Technology Zuellig Pharma Corp. wholesales and distributes pharmaceutical products. It offers an integrated network of regional distribution centers throughout Manila, Provincial Luzon, Visayas, and Mindanao. The company was founded in 1953 and is headquartered in Paranaque City, Philippines. | Pharmaceuticals: Major | Director/Board Member | |
| KYVERNA THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer | |
| Humboldt-Universität zu Berlin | College/University | Doctorate Degree | |
| Novartis Vaccines & Diagnostics SL | President | ||
| MIROMATRIX MEDICAL INC. | Biotechnology | Director/Board Member | |
PHOENIX Pharma SE
 PHOENIX Pharma SE Medical DistributorsDistribution Services PHOENIX Pharma SE operates as a healthcare provider. It engages in the distribution and supply of pharmaceutical products. It operates through the following business areas: Retail, Wholesale, and Pharma Services. The company was founded in 1994 and is headquartered in Mannheim, Germany. | Medical Distributors | Director/Board Member | |
Personalized Medicine Coalition
 Personalized Medicine Coalition Miscellaneous Commercial ServicesCommercial Services The Personalized Medicine Coalition promotes the understanding and adoption of personalized medicine concepts, services, and products. The private company is based in Washington and was founded by Patrick F. Terry. | Miscellaneous Commercial Services | Director/Board Member | |
PHOENIX Pharmahandel GmbH & Co. KG
 PHOENIX Pharmahandel GmbH & Co. KG Medical DistributorsDistribution Services PHOENIX Pharmahandel GmbH & Co. KG engages in the wholesale distribution of pharmaceutical and health products. It provides drugs and healthcare products to pharmacies, dispensing doctors, and medical institutions. The firm also offers services such as patient advice in the pharmacy and goods management system for pharmacies. The company was founded in 1994 and is headquartered in Mannheim, Germany. | Medical Distributors | Director/Board Member | |
MolecularMD Corp.
 MolecularMD Corp. Medical/Nursing ServicesHealth Services MolecularMD Corp. develops and commercializes molecular diagnostics for oncology applications. Its tests are designed to assist pharmaceutical companies with selection, monitoring and management of patients treated with molecularly-targeted cancer therapies. The firm integrates gold-standard and innovative platform technologies with custom clinical assay design and validation to accelerate all phases of clinical development, including FDA approval and commercialization of in vitro companion diagnostic tests for novel anticancer agents. The company was founded by Brian Druker, Sheridan G. Snyder, and Chad D. Galderisi in 2005 and is headquartered in Portland, OR. | Medical/Nursing Services | Director/Board Member | |
| IPSEN | Pharmaceuticals: Major | Chief Executive Officer | |
Toucan Capital Corp.
 Toucan Capital Corp. Investment ManagersFinance Toucan Capital Corp (Toucan Capital) is a private equity firm founded in 1997 by Linda F. Powers and Robert F. Hemphill. The firm is headquartered in Bethesda, Maryland. | Investment Managers | Private Equity Investor | |
| BAXALTA INC | Biotechnology | Corporate Officer/Principal | |
| BURCKHARDT COMPRESSION HOLDING AG | Industrial Machinery | Chairman |
Statistieken
Internationaal
| Verenigde Staten | 27 |
| Zwitserland | 7 |
| Duitsland | 7 |
| Frankrijk | 4 |
| Nederland | 3 |
Sectoraal
| Health Technology | 28 |
| Consumer Services | 8 |
| Commercial Services | 6 |
| Finance | 3 |
| Distribution Services | 3 |
Operationeel
| Director/Board Member | 184 |
| Corporate Officer/Principal | 66 |
| Independent Dir/Board Member | 40 |
| Chief Executive Officer | 39 |
| Chairman | 30 |
Sterkste connecties
| Insiders | |
|---|---|
| Todd Foley | 38 |
| William Greene | 26 |
| Daniel Vasella | 25 |
| Bruce Robertson | 24 |
| Julia Gregory | 22 |
| Liz Doherty | 20 |
| David Meek | 19 |
| Bruce A. Cohen | 19 |
| K. Hirth | 18 |
| Peter Maag | 18 |
| Vasant Narasimhan | 17 |
| Eric Cornut | 14 |
| Peter Piot | 14 |
| Ton Büchner | 14 |
| Andrin Oswald | 12 |
- Beurs
- Insiders
- Dirk Sauer
- Bedrijfsconnecties
